Neurological conditions associated with HIV remain major contributors to morbidity and
mortality and are increasingly recognized in the aging population on long-standing …

The identification of chemokine receptors as necessary co-receptors for HIV entry into target
cells represented a breakthrough in the understanding of the pathogenesis of this viral …

Background. We explored the establishment of abnormal blood-brain barrier (BBB)
permeability and its relationship to neuropathogenesis during primary human …

Objective: To determine the incidence, timing, and severity of neurologic findings in acute
HIV infection (pre–antibody seroconversion), as well as persistence with combination …

Background Many individuals with acute human immunodeficiency virus infection (AHI)
experience acute retroviral syndrome (ARS), which is associated with adverse long-term …

The prevalence of those affected by HIV-DSP will continue to grow with the aging population
of HIV-infected individuals. Compared to the diabetic neuropathy drug trials, trials in both …

Ongoing research has strongly suggested the role the immune system plays in the
pathogenesis of neuropathic pain. T cells appear to be one of the main regulators of the …

Neuropathic pain is a common complication of diabetes with high morbidity and poor
treatment outcomes. Accumulating evidence suggests the immune system is involved in the …

Results: Intraepidermal nerve fibre density was significantly reduced after 6 weeks of Tat
induction, similar to sensory neuropathy seen in clinical HIV infection. Tat induction through …

Primary human immunodeficiency virus type 1 (HIV-1) infection is defined as the period from
initial infection with HIV to complete seroconversion. Neurologic sequelae of primary HIV-1 …